Huli

About Huli

Huli, a health-tech company originating from Costa Rica, was founded in 2012 by Alejandro Vega, who currently serves as the CEO. Vega's background includes experience in investment banking, where he was involved in cross-border M&A transactions, and a tenure at General Electric after graduating from the Operations Management Leadership Program. He holds an MBA from The Wharton School and a Master of Arts in International Studies from the University of Pennsylvania, which provided him with a foundation in both business and global dynamics. This diverse experience spurred the creation of Huli to address inefficiencies in Latin American healthcare.

The company operates on a Software-as-a-Service (SaaS) model, providing a suite of products designed to connect and improve the efficiency of the healthcare ecosystem, including patients, doctors, hospitals, and pharmacies. Its client base ranges from individual healthcare professionals to large hospital networks and insurance companies across several Latin American countries, including Mexico, Costa Rica, and Panama. Revenue is generated through monthly fees from doctors for being listed on their platform and/or transaction fees for appointments booked through their service.

Huli's product offerings are centered around three main solutions. HuliPractice is a practice management software for healthcare professionals to manage scheduling, billing, and patient records. HuliHealth serves as an online medical directory where patients can find, research, and book appointments with doctors. Finally, HuliVida is a personal health management application for patients to manage their and their family's health information. The platform aims to bring transparency to healthcare by providing clear information on doctors' credentials and service costs.

Since its inception, the company has seen steady growth, serving over 13,000 doctors and 8 million patients. Huli has secured funding through several rounds, including an accelerator program in 2017, seed rounds in 2018 and 2019, and a later-stage venture capital round in 2023, with total funding reaching over $10 million from investors like Carao Ventures and VilCap Investments.